Targeting CCR2 with its antagonist suppresses viability, motility and invasion by downregulating MMP-9 expression in non-small cell lung cancer cells

被引:47
作者
An, Jun [1 ]
Xue, Ying [2 ]
Long, Meijun [3 ,4 ]
Zhang, Ge [2 ]
Zhang, Junhang [1 ]
Su, Hang [5 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Cardiothorac Surg, Guangzhou 510630, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Sch Pharmaceut Sci, Dept Microbial & Biochem Pharm, Guangzhou 510006, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 3, Breast Canc Ctr, Guangzhou 510630, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Thyroid & Breast Surg, Guangzhou 510630, Guangdong, Peoples R China
[5] Univ Texas Hlth Sci Ctr San Antonio, Dept Radiat Oncol, San Antonio, TX 78229 USA
关键词
CCR2; antagonist; MMP-9; non-small cell lung cancer; viability; motility and invasion; MONOCYTE CHEMOATTRACTANT PROTEIN-1; HUMAN BREAST-CANCER; MATRIX METALLOPROTEINASES; MACROPHAGE RECRUITMENT; ENDOTHELIAL-CELLS; SIGNALING PATHWAY; CHEMOKINE; METASTASIS; CCL2; ANGIOGENESIS;
D O I
10.18632/oncotarget.16837
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, which is the leading cancer killer in the world. Despite the recent advances in its diagnosis and therapy, the prognosis of NSCLC patients remains very poor, mainly due to the development of drug resistance and metastasis. Both the chemokine network and the matrix metalloproteinase (MMP) system play important roles in cancer cell metastasis. The disruption of CCL2/CCR2 chemokine signaling has been shown to suppress cancer cellviability and metastasis. CCL2-neutralizing antibodies, which have shown promising therapeutic efficacy in several cancer models, are not widely used due to technical issues. CCR2 antagonism has thus become an alternative method for cancer treatment. However, the effect of CCR2 antagonists on NSCLC progression remains poorly understood. Here, we investigated the effect of CCR2 antagonist (CAS445479-97-0) on the proliferation, migration and invasion of human lung adenocarcinoma A549 cells by using WST-1 cell viability assay, transwell migration assay, wound healing scratch assay and Matrigel invasion assay. We demonstrated that CCL2 treatment promoted A549 cell viability, motility and invasion by upregulating MMP-9 expression and that this induction was significantly suppressed by CAS 445479-97-0. Taken together, our data suggested that the CCR2 antagonist would be a potential drug for treating CCR2-positive NSCLC patients.
引用
收藏
页码:39230 / 39240
页数:11
相关论文
共 44 条
[1]
Activation of T-cell receptor signaling in peripheral T-cell lymphoma cells plays an important role in the development of lymphoma-associated hemophagocytosis [J].
An, Jun ;
Fujiwara, Hiroshi ;
Suemori, Koichiro ;
Niiya, Toshiyuki ;
Azuma, Taichi ;
Tanimoto, Kazushi ;
Ochi, Toshiki ;
Akatsuka, Yoshiki ;
Mineno, Junichi ;
Ozawa, Hidetoshi ;
Ishikawa, Fumihiko ;
Kuzushima, Kiyotaka ;
Yasukawa, Masaki .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (02) :176-185
[2]
[Anonymous], 2013, IEEE VEH TECHN C FAL
[3]
Co-Introduced Functional CCR2 Potentiates In Vivo Anti-Lung Cancer Functionality Mediated by T Cells Double Gene-Modified to Express WT1-Specific T-Cell Receptor [J].
Asai, Hiroaki ;
Fujiwara, Hiroshi ;
An, Jun ;
Ochi, Toshiki ;
Miyazaki, Yukihiro ;
Nagai, Kozo ;
Okamoto, Sachiko ;
Mineno, Junichi ;
Kuzushima, Kiyotaka ;
Shiku, Hiroshi ;
Inoue, Hirofumi ;
Yasukawa, Masaki .
PLOS ONE, 2013, 8 (02)
[4]
Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis [J].
Bonapace, Laura ;
Coissieux, Marie-May ;
Wyckoff, Jeffrey ;
Mertz, Kirsten D. ;
Varga, Zsuzsanna ;
Junt, Tobias ;
Bentires-Alj, Mohamed .
NATURE, 2014, 515 (7525) :130-133
[5]
Charo I F, 1999, Chem Immunol, V72, P30, DOI 10.1159/000058724
[6]
CCL2 (monocyte chemoattractant protein-1) and cancer [J].
Conti, I ;
Rollins, BJ .
SEMINARS IN CANCER BIOLOGY, 2004, 14 (03) :149-154
[7]
Monocyte chemoattractant protein-1 (MCP-1)/CCL2 secreted by hepatic myofibroblasts promotes migration and invasion of human hepatoma cells [J].
Dagouassat, Maylis ;
Suffee, Nadine ;
Hlawaty, Hanna ;
Haddad, Oualid ;
Charni, Faten ;
Laguillier, Christelle ;
Vassy, Roger ;
Martin, Loic ;
Schischmanoff, Pierre-Olivier ;
Gattegno, Liliane ;
Oudar, Olivier ;
Sutton, Angela ;
Charnaux, Nathalie .
INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (05) :1095-1108
[8]
New functions for the matrix metalloproteinases in cancer progression [J].
Egeblad, M ;
Werb, Z .
NATURE REVIEWS CANCER, 2002, 2 (03) :161-174
[9]
CCL2/CCR2 Chemokine Signaling Coordinates Survival and Motility of Breast Cancer Cells through Smad3 Protein- and p42/44 Mitogen-activated Protein Kinase (MAPK)-dependent Mechanisms [J].
Fang, Wei Bin ;
Jokar, Iman ;
Zou, An ;
Lambert, Diana ;
Dendukuri, Prasanthi ;
Cheng, Nikki .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (43) :36593-36608
[10]
Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals [J].
Gatti, Laura ;
Sevko, Alexandra ;
De Cesare, Michelandrea ;
Arrighetti, Noemi ;
Manenti, Giacomo ;
Ciusani, Emilio ;
Verderio, Paolo ;
Ciniselli, Chiara M. ;
Cominetti, Denis ;
Carenini, Nives ;
Corna, Elisabetta ;
Zaffaroni, Nadia ;
Rodolfo, Monica ;
Rivoltini, Licia ;
Umansky, Viktor ;
Perego, Paola .
ONCOTARGET, 2014, 5 (12) :4516-4528